Company News

BriaCell Therapeutics starts dosing in Phase I/IIa trial of Bria-IMT

BriaCell Therapeutics has started dosing patients in a Phase I/IIa trial to evaluate Bria-IMT in combination with pembrolizumab (Keytruda) or…